UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Clinical Trial Readiness for the Dystroglycanopathies
    Katherine D. Mathews
  2. Brain Connectivity in Adolescents
    Beng Choon Ho
  3. Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (VAMC)
    Daniel Vaena
  4. Study Patients with Advanced or Metastatic Untreated Soft Tissue Sarcoma
    Mohammed Milhem
  5. Antimullerian Hormone Levels in Girls and Adolescents Receiving Gonadotoxic Cancer Therapies
    Barbara Stegmann
  6. A multicenter, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with 177Lu-DOTA0-Tyr3-Octreotate to...
    David Bushnell
  7. Medamacs: The Medical Arm of Mechanical Circulatory Support
    Linda Cadaret
  8. A Phase II Evaluation of Ixabepilone (IND #59699, NSC #710428) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus
    David Bender
  9. Transfusion of Prematures (TOP) Trial
    Edward F. Bell
  10. A Phase II Evaluation of SU11248 (Sunitinib Malate) (IND #74019, NSC #736511) in the Treatment of Persistent or Recurrent Clear Cell Ovarian Carcinoma
    David Bender
  11. A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexat…
    Ayman El-Sheikh
  12. Cognitive and Psychiatric Functioning in Adults with Carcinoid Tumors
    Susan Schultz
  13. Phase III trial of enzalutamide (NSC # 766085) versus enzalutamide, abiraterone and prednisone for castration resistant metastatic prostate cancer
    Daniel Vaena
  14. Randomized Phase II Study Comparing the MET inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma
    Mohammed Milhem
  15. Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc P(1)
    Brian Link
  16. GOG 3001/ Amgen TRINOVA-3 - A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III…
    David Bender
  17. Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab...
    Ayman El-Sheikh
  18. A Phase III Randomized Trial of Gemcitabine (NSC# 613327) plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) vs. Observation for Uterus-limited, High Grade Uterine Leiomyosarcoma
    David Bender
  19. A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Lenalidomide...
    Brian Link
  20. A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton
    Brian Link

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.